Sourcing & evaluation
* source and evaluate external capabilities, technologies, and assets across all three pillars, drawing on drug discovery expertise and lsmd strategic needs.
* maintain a structured pipeline of external opportunities (asset acquisitions, research collaborations, discovery partnerships) with clear status tracking, strategic fit assessment, and next steps.
relationship building & ecosystem engagement
* build and sustain relationships across biotech, venture capital, academic, and cro ecosystems to surface aligned opportunities.
* represent sm e&i at partnering events (jpm, bio, bioeurope), venture showcases, and scientific conferences.
due diligence & governance
* lead cross-functional scientific due diligence by coordinating input from medicinal chemistry, computational chemistry, automation, pharmacology, biophysics, and ai/ml.
* author structured evaluation reports, investment theses, and governance presentations for senior leadership.
competitive intelligence & strategy
* maintain a living competitive landscape across sm e&i key technology domains (partnership activity, licensing transactions, acquisitions, and emerging science).
* translate landscape intelligence into actionable strategic recommendations.
cross-functional collaboration
* partner with therapeutic area search & evaluate, lilly research labs, catalyze360, and corporate bd to ensure portfolio coherence and execution quality.
basic qualifications
* phd (7+ years) or master’s (10+ years) in pharmaceutical or biotechnology r&d with foundation in drug discovery or translational science.
* 3+ years in external innovation/search and evaluation/business development scouting (or similar) involving systematic evaluation of external scientific opportunities.
additional skills/preferences
* broad drug discovery literacy (chemistry, biology, pharmacology, ai/ml, automation, translational science) with ability to coordinate/synthesize specialist input.
* experience leading structured scientific due diligence for licensing/collaboration/investment.
* strong written communication for evaluation reports/governance materials.
* familiarity with external biotech/health-tech ecosystem, including venture-backed/early-stage engagement.
* familiarity with at least two technology areas: macrocyclic drug design, targeted protein degradation, ai/ml-driven drug discovery, automation, protein–protein interaction modulators, dna-encoded libraries.
* exposure to deal structures (research collaborations, licensing, option agreements, asset acquisitions).
* strong business sense; ability to persuade/influence; track record building trust across functions.
* ability to manage multiple concurrent evaluations; collaborative, high-autonomy team fit.
additional information
* supports work across diabetes/obesity/cardiometabolic, neuroscience, immunology, oncology, genetic medicines, advanced modalities.
* up to 40% travel (domestic and international).
benefits (as explicitly stated)
* company bonus for full-time equivalent employees (depending on company and individual performance).
* 401(k), pension, vacation; medical/dental/vision/prescription; flexible benefits; life insurance; time off/leave; well-being benefits (eap, fitness, clubs/activities).
#j-18808-ljbffr